4/7
08:00 am
rxrx
Recursion to Participate in Upcoming Investor Conferences
Low
Report
Recursion to Participate in Upcoming Investor Conferences
4/6
05:38 pm
rxrx
Recursion Pharmaceuticals Inc. (RXRX) Partners with Citeline to Develop AI-Powered ClinTech Platform [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals Inc. (RXRX) Partners with Citeline to Develop AI-Powered ClinTech Platform [Yahoo! Finance]
4/2
04:38 am
rxrx
Expanded Citeline Data Partnership and CMO Transition Could Be A Game Changer For Recursion Pharmaceuticals (RXRX) [Yahoo! Finance]
Medium
Report
Expanded Citeline Data Partnership and CMO Transition Could Be A Game Changer For Recursion Pharmaceuticals (RXRX) [Yahoo! Finance]
4/1
08:13 am
rxrx
1 Beaten-Down AI Stock to Buy and 1 to Avoid [Yahoo! Finance]
Low
Report
1 Beaten-Down AI Stock to Buy and 1 to Avoid [Yahoo! Finance]
3/31
09:00 am
rxrx
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
Medium
Report
Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform
3/31
07:11 am
rxrx
2 AI Healthcare Stocks to Buy Right Now [Yahoo! Finance]
Medium
Report
2 AI Healthcare Stocks to Buy Right Now [Yahoo! Finance]
3/28
01:05 am
rxrx
Medium
Report
3/26
07:41 am
rxrx
Assessing Recursion Pharmaceuticals (RXRX) Valuation After Recent Share Price Weakness And Split Fair Value Views [Yahoo! Finance]
Low
Report
Assessing Recursion Pharmaceuticals (RXRX) Valuation After Recent Share Price Weakness And Split Fair Value Views [Yahoo! Finance]
3/25
07:59 am
rxrx
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Low
Report
Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
3/22
01:11 am
rxrx
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028 [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals Details AI-Driven Drug Pipeline, Sanofi/Roche Milestones, Runway to 2028 [Yahoo! Finance]
3/13
08:04 pm
rxrx
Jim Cramer on Recursion Pharmaceuticals: “It's a Let Down, Big Let Down” [Yahoo! Finance]
Low
Report
Jim Cramer on Recursion Pharmaceuticals: “It's a Let Down, Big Let Down” [Yahoo! Finance]
3/10
10:44 pm
rxrx
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Recent 1-Year Share Slump Accurately [Yahoo! Finance]
Neutral
Report
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Recent 1-Year Share Slump Accurately [Yahoo! Finance]
3/9
10:36 pm
rxrx
Recursion's First AI Clinical Proof Links Pipeline Progress With Valuation Gap [Yahoo! Finance]
Low
Report
Recursion's First AI Clinical Proof Links Pipeline Progress With Valuation Gap [Yahoo! Finance]
3/9
08:36 pm
rxrx
What Makes Recursion Pharmaceuticals (RXRX) So Attractive [Yahoo! Finance]
Low
Report
What Makes Recursion Pharmaceuticals (RXRX) So Attractive [Yahoo! Finance]
3/8
12:30 pm
rxrx
Can This AI Stock Bounce Back in 2026? [Yahoo! Finance]
Low
Report
Can This AI Stock Bounce Back in 2026? [Yahoo! Finance]
3/6
12:25 pm
rxrx
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating [Yahoo! Finance]
Low
Report
BoFA Lowers PT on Recursion Pharmaceuticals (RXRX), Keeps a Hold Rating [Yahoo! Finance]
3/2
04:43 pm
rxrx
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
Low
Report
Recursion: Nvidia Sells Out, Collaboration Still Alive, Data Ahead [Seeking Alpha]
2/28
07:02 pm
rxrx
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
Low
Report
Recursion's REC-4881 Milestone And Cash Runway Shift Risk Reward Profile [Yahoo! Finance]
2/28
01:30 am
rxrx
Low
Report
2/26
08:03 am
rxrx
Recursion Pharmaceuticals (RXRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
Low
Report
Recursion Pharmaceuticals (RXRX) had its "buy" rating reaffirmed by Needham & Company LLC. They now have a $8.00 price target on the stock.
2/25
05:43 pm
rxrx
Recursion Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals Q4 Earnings Call Highlights [Yahoo! Finance]
2/25
03:58 pm
rxrx
Recursion Pharmaceuticals (RXRX) had its "neutral" rating reaffirmed by Bank of America Corporation.
Low
Report
Recursion Pharmaceuticals (RXRX) had its "neutral" rating reaffirmed by Bank of America Corporation.
2/25
03:22 pm
rxrx
Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic [Seeking Alpha]
Low
Report
Recursion Pharmaceuticals Q4: Why My December Buy Call Was Too Optimistic [Seeking Alpha]
2/25
01:14 pm
rxrx
Recursion (RXRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
Low
Report
Recursion (RXRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]
2/25
01:04 pm
rxrx
Recursion Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Recursion Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]